Your browser doesn't support javascript.
loading
Safety and immunogenicity of PXVX0317, an aluminium hydroxide-adjuvanted chikungunya virus-like particle vaccine: a randomised, double-blind, parallel-group, phase 2 trial.
Bennett, Sean R; McCarty, James M; Ramanathan, Roshan; Mendy, Jason; Richardson, Jason S; Smith, Jonathan; Alexander, Jeff; Ledgerwood, Julie E; de Lame, Paul-André; Royalty Tredo, Sarah; Warfield, Kelly L; Bedell, Lisa.
  • Bennett SR; Emergent BioSolutions, Gaithersburg, MD, USA.
  • McCarty JM; Stanford University School of Medicine, Stanford, CA, USA.
  • Ramanathan R; Emergent BioSolutions, Gaithersburg, MD, USA; GlaxoSmithKline Pharmaceuticals, Philadelphia, PA, USA.
  • Mendy J; Emergent BioSolutions, Gaithersburg, MD, USA.
  • Richardson JS; Emergent BioSolutions, Gaithersburg, MD, USA.
  • Smith J; Emergent BioSolutions, Gaithersburg, MD, USA; VLP Therapeutics, Gaithersburg, MD, USA.
  • Alexander J; Emergent BioSolutions, Gaithersburg, MD, USA.
  • Ledgerwood JE; Vaccine Research Center, US National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • de Lame PA; Anabase International, Lambertville, NJ, USA.
  • Royalty Tredo S; Emergent BioSolutions, Gaithersburg, MD, USA.
  • Warfield KL; Emergent BioSolutions, Gaithersburg, MD, USA.
  • Bedell L; Emergent BioSolutions, Gaithersburg, MD, USA. Electronic address: bedelll@ebsi.com.
Lancet Infect Dis ; 22(9): 1343-1355, 2022 09.
Article en En | MEDLINE | ID: mdl-35709798
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas de Partículas Similares a Virus / Fiebre Chikungunya Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas de Partículas Similares a Virus / Fiebre Chikungunya Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Año: 2022 Tipo del documento: Article